On Thursday, Shares of National Bank of Greece S.A. (NYSE:NBG), lost -0.91% to $1.09, despite Financial stocks were broadly higher Thursday’s afternoon with the NYSE Financial Sector Index nearly 0.7% and the S&P Financial 100 Index also climbing 0.7%.
National Bank of Greece S.A., together with its auxiliaries, provides diversified financial services. The company is involved in retail and commercial banking, asset administration, investment banking, brokerage, and insurance activities. It offers current accounts, deposit multiproducts, deposits in foreign currency, savings accounts, sight accounts, and time deposit accounts.
Shares of Huntington Bancshares Incorporated (NASDAQ:HBAN), inclined 1.32% to $11.51, during its last trading session.
On June 10, Huntington Bancshares Incorporated, brings back the Hall of Banking in a new series of brand advertising now on television and radio stations in its markets. Building on the tremendous success from last year’s campaign, the new ads continue to challenge “banking as usual” by showing how Huntington is different than other banks.
The ads once again feature a Huntington Banker teaching a traditional banker the better way to serve customers. In a survey of consumers by the global research firm, TNS, last year’s ads with the same actors generated greater positive feelings, or favorability, than ads from Huntington’s competitors within their markets.
Huntington estimates that more than one million of their consumer customers and 100,000 business customers have benefited from the service since it was introduced in July 2014—with all deposits, customers need to consult their Funds Availability Policy, because the deposits may not be right away accessible.
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
Finally, AbbVie Inc. (NYSE:ABBV), ended its last trade with 1.79% gain, and closed at $68.98.
The board of directors of AbbVie, declared a quarterly cash dividend of $0.51 per share. The cash dividend is payable Aug. 14, 2015 to stockholders of record at the close of business on July 15, 2015.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, counting those with compensated cirrhosis; Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in people with HIV-1; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 infection; and Synagis to prevent respiratory syncytial virus infection in high risk infants.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
